Evidence map›Paper›PMID 40059844›Full record

ArticleBiochemistry2025

Accessibility of Carboxypeptidase A-bound Zinc to Chelation Correlates with an Intermediate State in the Protein's Unfolding Pathway.

Danica L Goulet, Matthew W Bignucolo, Stefan Siemann

Abstract read
In one paragraph

Article in Biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Danica L GouleteConsult Centre of Excellence, The Ottawa Hospital, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada.
Matthew W BignucoloSchool of Natural Sciences, Laurentian University, 935 Ramsey Lake Road, Sudbury, Ontario P3E 2C6, Canada.ORCID 0009-0007-5567-1628
Stefan SiemannSchool of Natural Sciences, Laurentian University, 935 Ramsey Lake Road, Sudbury, Ontario P3E 2C6, Canada.ORCID 0000-0002-3316-6598

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In view of the emerging role of metal ions in improper protein folding (a phenomenon associated with a variety of diseases), new tools to characterize structural changes that accompany folding transitions are highly sought. Using a combination of fluorescence spectroscopy and studies involving the chromophoric chelator 4-(2-pyridylazo)resorcinol (PAR), we here show that the prototypical zinc protease carboxypeptidase A (CPA) unfolds in the presence of guanidine hydrochloride via a previously unidentified folding intermediate that resembles a molten globular state and retains the zinc ion. The spontaneous dissociation of the metal ion from CPA was observed only upon transition of the intermediate to the fully unfolded state of the protein. Furthermore, an analysis of zinc ion binding during CPA unfolding using PAR revealed the intermediate state to directly correlate with the ability of the chelator to gain access to the active site and to associate with the protein-bound metal ion. This observation is indicative of CPA's active site being PAR-inaccessible in the native state but becoming PAR-accessible in the folding intermediate. Taken together, the current study demonstrates the usefulness of PAR as a simple spectrophotometric tool to assess structural changes during the unfolding of CPA and potentially other zinc proteins. Hence, zinc accessibility probes (ZAPs) such as PAR may find utility in gaining further insight into the mechanism(s) of metalloprotein folding.

Indexed as

Carboxypeptidases AChelating AgentsProtein UnfoldingZincGuanidineProtein FoldingResorcinolsSpectrometry, FluorescenceCarboxypeptidases AChelating AgentsGuanidineResorcinolsZinc

Identifiers

PMID40059844
PMCPMC11925051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.